URGN position history
The shares of Urogen Pharma (URGN) that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 244,165 shares, $4.1M, <0.01% of portfolio
- 2021 Q4: 186,493 shares, $1.8M, <0.01% of portfolio, Reduce −23.6%
- 2022 Q1: 333,472 shares, $2.9M, 0.01% of portfolio, Add +78.8%
- 2022 Q2: 302,124 shares, $1.6M, <0.01% of portfolio, Reduce −9.4%
- 2022 Q3: 281,701 shares, $2.3M, 0.02% of portfolio, Reduce −6.8%
- 2022 Q4: 196,938 shares, $1.7M, 0.02% of portfolio, Reduce −30.1%
- 2023 Q1: 270,746 shares, $2.5M, 0.02% of portfolio, Add +37.5%
- 2023 Q2: 201,918 shares, $2.1M, 0.01% of portfolio, Reduce −25.4%
- 2023 Q3: 215,272 shares, $3M, 0.02% of portfolio, Add +6.6%
- 2023 Q4: 161,525 shares, $2.4M, 0.01% of portfolio, Reduce −25.0%
- 2024 Q1: 146,329 shares, $2.2M, 0.02% of portfolio, Reduce −9.4%
- 2024 Q2: 151,781 shares, $2.5M, 0.02% of portfolio, Add +3.7%
- 2024 Q3: 121,634 shares, $1.5M, 0.01% of portfolio, Reduce −19.9%
- 2024 Q4: 140,148 shares, $1.5M, 0.01% of portfolio, Add +15.2%
- 2025 Q1: 185,790 shares, $2.1M, 0.02% of portfolio, Add +32.6%
- 2025 Q2: 166,094 shares, $2.3M, 0.02% of portfolio, Reduce −10.6%
- 2025 Q3: 126,720 shares, $2.5M, 0.02% of portfolio, Reduce −23.7%
- 2025 Q4: 121,484 shares, $2.8M, 0.02% of portfolio, Reduce −4.1%
- 2026 Q1: 115,545 shares, $2.1M, 0.02% of portfolio, Reduce −4.9%
- 2026 Q2: 101,508 shares, $3.7M, 0.02% of portfolio, Reduce −12.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|